首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Bmc rheumatology

缩写:

ISSN:N/A

e-ISSN:2520-1026

IF/分区:2.5/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引606
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Lina S Alahmadi,Ahmed M Alhazmi,Samaher I Alaauldeen et al. Lina S Alahmadi et al.
Introduction: Rheumatoid arthritis (RA) in adult patients, there is contradictory evidence regarding Abatacept's safety profile (ABA). This study aims to assess the safety and efficacy of ABA in adult patients in Saudi Ar...
Thabuna Sivaprakasam,Prachaya Nitchaikulvatana,Jodi Gedallovich et al. Thabuna Sivaprakasam et al.
Background: Immune checkpoint inhibitors (ICIs) have become a cornerstone in the treatment of metastatic melanoma. Several case reports have documented IgG4-related disease (IgG4-RD) as an adverse event following ICI ther...
Natalie Li,Stephanie Frade,Lucinda Roper et al. Natalie Li et al.
Background: Idiopathic inflammatory myopathies (IIM) are a group of related chronic autoimmune diseases characterized by muscle inflammation and numerous other potential organ specific manifestations. People with IIM ofte...
Susann Patschan,Constantin Remus,Inga Claus et al. Susann Patschan et al.
Background and aim: Spondyloarthritides (SpA) are common entities of the inflammatory rheumatic type. There are still 3 relevant problems in everyday clinical practice: early disease detection, cardiovascular risk assessm...
Abdalrahim Daraghma,Lamar Baidoun,Samaa Nazzal et al. Abdalrahim Daraghma et al.
Background: Behçet's Disease (BD) is a chronic, systemic vasculitis of unknown etiology that affects multiple organ systems. It is characterized by recurrent oral and genital ulcers, ocular involvement, affecting arterie...
Yuzhe Cheng,Jingyi Ma,Jun Niu Yuzhe Cheng
Objective: Anifrolumab, a monoclonal antibody targeting the type I interferon-α receptor, has been approved for the treatment of moderate-to-severe systemic lupus erythematosus (SLE). This study aimed to assess its safet...
Delphine Bertrand,Elias De Meyst,Michaël Doumen et al. Delphine Bertrand et al.
Background: Rituximab is known as an efficacious drug for the treatment of Rheumatoid Arthritis (RA). The original administration schedule consisted of two infusions of 1000 mg with a 2-week interval. We aimed to explore ...
Harjit Singh Nalwa,Tushar Singh Barwal,Parul Chugh et al. Harjit Singh Nalwa et al.
Background: Methotrexate (MTX) is the most commonly used disease-modifying antirheumatic drug (DMARD) for treating rheumatoid arthritis (RA). However, MTX use is associated with gastrointestinal adverse effects in a numbe...
Mjellma Rexhepi,Blana Krasniqi,Kreshnik Hoti et al. Mjellma Rexhepi et al.
Background: Rheumatoid arthritis (RA) is a progressive autoimmune disease. During complex therapy, vitamin D supplementation could have an immunomodulatory effect and improve disease activity. ...